ITMCTR2000003375已完成4 期
Effect and Safety of Naomaili Granules for the Treatment of Acute Stroke: a Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
试验速览
- 阶段
- 4 期
- 状态
- 已完成
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 性别
- All
入选标准
- •1. Those who meet the western medicine diagnosis standard of acute ischemic stroke (belong to anterior circulation infarction);
- •2. According to the syndrome differentiation of traditional Chinese medicine, Qi deficiency and blood stasis syndrome have scores of >= 10 points respectively;
- •3. Patients whose course of disease is 7-14 days after onset (including 7 days and 14 days);
- •4. NIHSS score >= 4 and <= 20;
- •5. Aged 40-80 years;
- •6. Patients with the first onset or recurrent stroke have fully recovered before the onset of the disease (MRS score is 0-1);
- •7. Signing informed consent.
排除标准
- •1. There was a history of cerebral hemorrhage in the past six months;
- •2. Patients with clinical manifestations of consciousness disorders;
- •3. The patients who were treated with blood vessels (such as thrombolysis, arterial thrombectomy, super early thrombus aspiration and stenting) within 6 hours after the onset of the disease;
- •4. It was confirmed by examination that cerebral embolism was caused by brain tumor, brain injury, brain parasitosis, metabolic disorder, rheumatic heart disease and coronary heart disease;
- •5. TIA attack, cerebral hemorrhage, subarachnoid hemorrhage and asymptomatic cerebral infarction;
- •6. Patients who can't take orally;
- •7. Oral anticoagulants;
- •8. Those with other diseases affecting the function of limb activity, such as lameness, osteoarthritis (active stage), rheumatoid arthritis (active stage), gouty arthritis, etc., may affect the nerve or function examination;
- •9. After treatment, systolic blood pressure >= 160 mmHg or blood glucose >= 22.22 mmol / L;
- •10. Patients with active ulcer and bleeding tendency;
- •11. In patients with severe heart and lung diseases and chronic liver and kidney dysfunction, ALT and AST of liver function damage were more than 1.5 times of the upper limit of normal, and renal function damage (BUN > 1.2 times of the upper limit of normal, Cr > the upper limit of normal);
- •12. Pregnant or lactating women;
- •13. Disabled patients (blind, deaf, dumb, mental disorder, mental disorder, physical disability) as prescribed by law;
- •14. Those who are known to be allergic to the ingredients of the drug and have allergic constitution;
- •15. In the opinion of the investigator, there are any patients who are not suitable for inclusion or influence the factors of participation or completion of the study;
- •16. Patients who participated in other clinical trials within 3 months.
研究者
相似试验
已完成
1 期
effect of Triphaladi Granules on DiabetesCTRI/2011/12/002195IPGTRA Gujarat Ayurved University50
尚未招募
不适用
Effect and Safety of Elian Granules for the Treatment of Chronic Atrophic Gastritis: a Randomized, Double-Blind, Placebo-Controlled, Multicenter TrialChronic Atrophic GastritisITMCTR2000003929Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
已完成
不适用
Safety and efficacy study of Triphala and Trimad in obseityCTRI/2017/11/010409Interactive Research school for health Affairs120
尚未招募
3 期
Binafuxi granule in the treatment of common cold (heat syndrome): a phase III clinical trialCommon cold with heat syndromeITMCTR2100005376West China Hospital, Sichuan University
尚未招募
1 期
In this trial Triphala(combination of three herbal drug)will be given to the overweight child to see its effect on weightless.CTRI/2018/05/013926All India Institute of Ayurveda